<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC2802127/results/search/funder/results.xml">
   <result pre="treat human cases of herpes encephalitis and neonatal herpes. The" exact="basis" post="for activity of HBPG was first thought to involve"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3065466/results/search/funder/results.xml">
   <result pre="planning to prepare for pandemic influenza, seems sensible on the" exact="basis" post="of past experience. Attack rates observed during the pandemics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3136400/results/search/funder/results.xml">
   <result pre="of viral variants with reduced propensity. This study offers a" exact="basis" post="for the clinical estimation of three-part combination of PEG"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3184032/results/search/funder/results.xml">
   <result pre="review article is structured to discuss antiviral therapeutics on the" exact="basis" post="of these 3 major antiviral categories, with the caveat"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3185584/results/search/funder/results.xml">
   <result pre="in acquisition of resistance to NRTIs. Figure 1 illustrates the" exact="basis" post="for the preferred selection of K65R in subtype C."/>
   <result pre="mutation that is more commonly selected in subtype B. The" exact="basis" post="for this difference is a nucleotide polymorphism at codon"/>
   <result pre="for PIs and amplification of primary resistance mutations on the" exact="basis" post="of background polymorphisms. Few data on the potential for"/>
   <result pre="in non- B subtypes has rarely been reported on the" exact="basis" post="of single drugs or NRTI backbones but, rather, mutations"/>
   <result pre="frequency by subtype and treatment experience: Extension of the HIVseq" exact="program" post="to seven non-B subtypesAIDS20062064365116514293 23.NovitskyVWesterCWDeGruttolaVBussmannHGaseitsiweSThomasAMoyoSMusondaRVan WidenfeltEMarlinkRGet al.The reverse transcriptase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3207218/results/search/funder/results.xml">
   <result pre="peramivir for 2009 influenza a (H1N1) under an emergency IND" exact="program" post="in the United States. Clinical Infectious Diseases2011; 52: 695–706.21367722"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3262966/results/search/funder/results.xml">
   <result pre="each chromatographic condition, the matrix effects were evaluated on the" exact="basis" post="of spiked poultry muscle samples using only a methanolic"/>
   <result pre="(&amp;lt;120 μg kg−1) and suggested a complementary model. On the" exact="basis" post="of this model the RSDRL and RSDr are acceptable"/>
   <result pre="possible. Therefore, the decision limit (CCα) was calculated on the" exact="basis" post="of zero tolerance in accordance with 2002/657/EC [1] to"/>
   <result pre="blank population (α-error is 1%). CCα was calculated on the" exact="basis" post="of the bandwidth of the signal in blank samples"/>
   <result pre="found non-compliant (β-error is 5%). CCβ was determined on the" exact="basis" post="of the bandwidth of the signal in blank samples"/>
   <result pre="Selectivity The selectivity of the method was studied on the" exact="basis" post="of a practical and a theoretical study. Firstly, the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3291404/results/search/funder/results.xml">
   <result pre="of time and resources. Choices must be made on the" exact="basis" post="of historic and current observations. At one time, a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3322031/results/search/funder/results.xml">
   <result pre="(Table) and were extreme outliers (data not shown). On the" exact="basis" post="of cycling probe real-time PCR assay, these viruses had"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3323435/results/search/funder/results.xml">
   <result pre="of state and local readiness for implementing a large-scale antiviral" exact="program" post="has been limited. As a result, pre-pandemic assessments have"/>
   <result pre="described how reimbursement issues in Medi-Cal (California's state Medicaid insurance" exact="program" post="for the poor and underserved) made it difficult to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3854647/results/search/funder/results.xml">
   <result pre="of Public Health TackenMMulderJVisscherSTiersmaWDonkersJVerheijRBraspenningJMonitoring vaccination rate Dutch national influenza prevention" exact="program" post="2009 [in Dutch]2010LINH: Nijmegen/Utrecht Van EssenGABuevingHJVoordouwACGBergHFVan der LaanJRde Jeude"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC3898391/results/search/funder/results.xml">
   <result pre="existing public health programs and not considered to be public" exact="health research." post="The survey included 22 questions regarding influenza vaccines, antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4066892/results/search/funder/results.xml">
   <result pre="protein The full-sized recombinant UL9 protein was synthesized on the" exact="basis" post="of the modified plasmid PET14 carrying a HSV1 UL9"/>
   <result pre="a consequence, the fluorescence intensity increases dramatically. This provides a" exact="basis" post="for the application of molecular beacon probes as sensitive"/>
   <result pre="USA19989512890128959789010 DohertyA. J.SerpellL. C.PontingCh. P.The helix-hairpin-helix DNA-binding motif: A structural" exact="basis" post="for non-sequence-specific recognition of DNANucleic Acids Research199624248824928692686 FiererD. S.ChallbergM."/>
   <result pre="Symposium Quantitative Biology198347367378 HaddenJ. M.DéclaisA. C.CarrS. B.LilleyD. M.PhillipsS. E.The structural" exact="basis" post="of Holliday junction resolution by T7 endonuclease INature200744962162417873858 HeX.LehmanI."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4195804/results/search/funder/results.xml">
   <result pre="membrane (M) and nucleocapsid (N) proteins [5, 6]. On the" exact="basis" post="of phylogenic analyses, evolutionary studies have shown that SARS-CoV"/>
   <result pre="peptide as the substrate and with structure-based design on the" exact="basis" post="of the crystal structures of the product-bound form of"/>
   <result pre="screen for small molecules that block SARS-CoV replication on the" exact="basis" post="of their inhibition of nsp3 or PLP. The basis"/>
   <result pre="the basis of their inhibition of nsp3 or PLP. The" exact="basis" post="for the screen was that stimulated expression of nsp3"/>
   <result pre="oligonucleotides into single strands in an ATP-dependent reaction. On the" exact="basis" post="of this activity, helicases can be divided into two"/>
   <result pre="the viral helicaseAntimicrob Agents Chemother5620124718472822733076 20AnandK.ZiebuhrJ.WadhwaniP.MestersJ.R.HilgenfeldR.Coronavirus main proteinase (3CLpro) structure:" exact="basis" post="for design of anti-SARS drugsScience30020031763176712746549 21••YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.The crystal structures of"/>
   <result pre="compounds as inhibitors of 3CL protease of SARS-CoVFEBS Lett574200411612015358550 27LeeC.C.KuoC.J.HsuM.F.LiangP.H.FangJ.M.ShieJ.J.WangA.H.Structural" exact="basis" post="of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4247767/results/search/funder/results.xml">
   <result pre="combination theory The Loewe additivity and Bliss independence form the" exact="basis" post="of sophisticated protocols for assessing drug combinations, especially in"/>
   <result pre="U S A20081054832483710.1073/pnas.071137210518362342 12.ShenLRabiSASedaghatARShanLLaiJXingSSilicianoRFA critical subset model provides a conceptual" exact="basis" post="for the high antiviral activity of major HIV drugsSci"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4313645/results/search/funder/results.xml">
   <result pre="coverage. We categorized all Texas ZIP code areas on the" exact="basis" post="of underinsured population sizes into small (&amp;lt;1,000 persons), medium"/>
   <result pre="exclude or include particular pharmacies and pharmacy chains. On the" exact="basis" post="of user input, the tool solves a family of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4353273/results/search/funder/results.xml">
   <result pre="Guidelines document ‘The use of antiviral drugs for influenza: A" exact="foundation" post="document for practitioners’, published in the Autumn 2013 issue"/>
   <result pre="recommendations for adjustment to LTCF outbreak control measures on the" exact="basis" post="of documented vaccine mismatch. Influenza seasons dominated by A(H3N2)"/>
   <result pre="Canada Guideline ‘The use of antiviral drugs for influenza: A" exact="foundation" post="document for practitioners’ (6). The essential points in this"/>
   <result pre="For surveillance purposes, FluWatch defines an influenza outbreak on the" exact="basis" post="of two or more cases of ILI within a"/>
   <result pre="19, 2015). 6.AokiFYAllenUDStiverHGLaverdièreMEvansGAThe use of antiviral drugs for influenza: A" exact="foundation" post="document for practitionersCan J Infect Dis Med Microbiol201324Suppl C1C15C"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4353274/results/search/funder/results.xml">
   <result pre="Antimicrob Ther2003511239 6.AokiFYAllenUDStiverHGLaverdièreMEvansGAThe use of antiviral drugs for influenza: A" exact="foundation" post="document for practitionersCan J Infect Did Med Microbiol201324Suppl C1C15C"/>
   <result pre="Updated from: The use of antiviral drugs for influenza: A" exact="foundation" post="document for practitioners (6) Medication Treatment (5 days) Chemoprophylaxis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4531042/results/search/funder/results.xml">
   <result pre="responded appropriately to letermovir.40 Letermovir was used in a compassionate" exact="program" post="for treatment of severe CMV disease in a lung"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4623666/results/search/funder/results.xml">
   <result pre="and ρi is the vaccine coverage in the age group" exact="i" post="of the individual who is making the offer (see"/>
   <result pre="social, and health economic factors. Our assumption for HIV vaccine" exact="program" post="design was based on experience with the HPV vaccine,"/>
   <result pre="US offers attractive to vaccinated individuals. Implementation of a vaccination" exact="program" post="at year 50 covering 75% of entering 15-year-olds, and"/>
   <result pre="actual vaccine coverage according to the parameter k. The vaccine" exact="program" post="decreases the perceived prevalence of HIV among HIV− individuals"/>
   <result pre="though US is still offered and practiced. After the vaccine" exact="program" post="is implemented, the rate of US acts between HIV+"/>
   <result pre="actor is minimal. However, these results suggest that a booster" exact="program" post="may be beneficial in older age categories, if vaccine"/>
   <result pre="coverage is is implemented at age 15, with the age" exact="i" post="impacting Equation 4 0.75 (i = 15–25), 0 (i = 26+) d adjustment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4654359/results/search/funder/results.xml">
   <result pre="a number of studies reporting the time taken to translate" exact="health research," post="concluding that 17 years was the most likely estimate despite"/>
   <result pre="biomedical research take? Studying the time taken between biomedical and" exact="health research" post="and its translation into products, policy, and practice. Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC4865845/results/search/funder/results.xml">
   <result pre="these hits with three additional siRNAs per gene. On the" exact="basis" post="of the calculated cSSMD (collective strictly standardized mean difference)"/>
   <result pre="CHIKV vRNA replication. Rational identification of antiviral drugs On the" exact="basis" post="of the demonstration of the antiviral activity of all"/>
   <result pre="followed by automated microscopy and single object analysis. On the" exact="basis" post="of the results of the eight different dilutions, dose–response"/>
   <result pre="observed' confidence criterion. Enriched molecular functions were selected on the" exact="basis" post="of their statistical significance (P≤0.01 was used as threshold)."/>
   <result pre="8 h p.i. (n=18, 9, 8, 9, 9 and 9 for" exact="m" post="and n=18, 9, 9, 9, 9 and 9 for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC5228644/results/search/funder/results.xml">
   <result pre="disease, and thus, cirrhotic patients are candidates for active surveillance" exact="program" post="of HCC development.[37] In addition, cirrhotic patients with HBV"/>
   <result pre="al.Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance" exact="program" post="of cirrhotic and noncirrhotic patients with chronic hepatitis C"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC5644647/results/search/funder/results.xml">
   <result pre="viruses with multiple effects on virus replication and propagation. Molecular" exact="basis" post="of ribavirin resistanceCurr. Opin. Virol.20148101510.1016/j.coviro.2014.04.01124846716 72.LafeuilladeA.HittingerG.ChadapaudS.Increased mitochondrial toxicity with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC5923505/results/search/funder/results.xml">
   <result pre="of nucleoside analogs acting through innate immunity strengthens the molecular" exact="basis" post="for their therapeutic application as broad-spectrum antiviral drugs. Nucleoside"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6025560/results/search/funder/results.xml">
   <result pre="It is not itself oncogenic, but serves as the molecular" exact="basis" post="of the latent state of EBV infection [5]. No"/>
   <result pre="affect downstream targets indirectly. 9. Cidofovir Finally, there is some" exact="basis" post="for using an antiviral drug in tumorous tissue. Cidofovir"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6027266/results/search/funder/results.xml">
   <result pre="activity was proposed by Namanja and co-workers [26] on the" exact="basis" post="of the solved crystal structure of mouse P-gp [69]."/>
   <result pre="the possibilitiesPharmacol. Ther.2004104294510.1016/j.pharmthera.2004.08.00115500907 69.AllerS.G.YuJ.WardA.WengY.ChittaboinaS.ZhuoR.HarrellP.M.TrinhY.T.ZhangQ.UrbatschI.L.et al.Structure of P-glycoprotein reveals a molecular" exact="basis" post="for poly-specific drug bindingScience20093231718172210.1126/science.116875019325113 70.NamanjaH.A.EmmertD.HrycynaC.A.ChmielewskiJ.Homodimers of the antiviral abacavir"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6439212/results/search/funder/results.xml">
   <result pre="natural antiviral compounds of plant origin were selected on the" exact="basis" post="of their published in vitro or vivo antiviral activities."/>
   <result pre="were set to 150, 0.2 and 5 respectively. On the" exact="basis" post="of binding energy (ΔG), best docked structures were saved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6780377/results/search/funder/results.xml">
   <result pre="Since host protease required for virus polyprotein formation is a" exact="basis" post="of DENV replication, it can be a strong target"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6789623/results/search/funder/results.xml">
   <result pre="The number of infectious PDCoV particles was determined on the" exact="basis" post="of the 50% tissue culture infectious dose (TCID50) in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6792045/results/search/funder/results.xml">
   <result pre="of Shandong ProvinceZR2018PC012ZR2015CL033 Projects of medical and health technology development" exact="program" post="in Shandong province2015WS0123 Taishan Scholars program of Shandong Provincets201511056"/>
   <result pre="and health technology development program in Shandong province2015WS0123 Taishan Scholars" exact="program" post="of Shandong Provincets201511056 This work was supported by the"/>
   <result pre="numbers ZR2018PC012, ZR2015CL033], Projects of medical and health technology development" exact="program" post="in Shandong province, China [grant number 2015WS0123] and W.S."/>
   <result pre="number 2015WS0123] and W.S. was supported by the Taishan Scholars" exact="program" post="of Shandong Province, China [grant number ts201511056]. fig-count: table-count:"/>
   <result pre="twice (Late stage treatment). Discussion The infection model provides a" exact="foundation" post="for the evaluation of the efficacy of novel antiviral"/>
   <result pre="vitro and in vivo. This neonatal murine model lays a" exact="foundation" post="for studying the pathogenesis of CVA4 and for evaluating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6809658/results/search/funder/results.xml">
   <result pre="enterally administered pooled immunoglobulin (IVIG) are used off-label on the" exact="basis" post="of expert opinion. Nitazoxanide and ribavirin show antiviral activity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6810993/results/search/funder/results.xml">
   <result pre="effectiveness of Accessible Care (low-threshold care in a syringe service" exact="program" post="located in New York City) with Usual Care (referral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6821460/results/search/funder/results.xml">
   <result pre="of 2′-C-Me-A, GA, or the combination thereof, respectively. On the" exact="basis" post="of this observation alone, the conclusion would be that"/>
   <result pre="M., ProdromouC., O'BrienR., LadburyJ. E., PiperP. W., PearlL. H., Structural" exact="basis" post="for inhibition of the Hsp90 molecular chaperone by the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6831721/results/search/funder/results.xml">
   <result pre="viruses with multiple effects on virus replication and propagation. Molecular" exact="basis" post="of ribavirin resistance. Curr. Opin. Virol.8, 10–15. 10.1016/j.coviro.2014.04.01124846716 BeheraA."/>
   <result pre="Replication. PloS Negl. Trop. Dis.8, e2994. 10.1371/journal.pntd.000299425058001 Menéndez-AriasL. (2013). Molecular" exact="basis" post="of human immunodeficiency virus type 1 drug resistance: overview"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6835697/results/search/funder/results.xml">
   <result pre="which are essential for mannose-binding, are noted with blue and" exact="orange" post="arrows, respectively. Wild-type GRFT has a non-standard amino acid"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6843332/results/search/funder/results.xml">
   <result pre="the extent of correlation of the movements between two nodes," exact="i" post="and j, representing amino acid residues. CC values vary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6856223/results/search/funder/results.xml">
   <result pre="Res.85 (1), 190–200. 10.1016/j.antiviral.2009.09.00119744523 TsudaT. (2012). Dietary anthocyanin-rich plants: biochemical" exact="basis" post="and recent progress in health benefits studies. Mol. Nutr."/>
   <result pre="antiviral and chemoprotective effects of strawberry anthocyanins. WleklikM.LuczakM.PanasiakW.KobusM.Lammer-ZarawskaE. (1988). Structural" exact="basis" post="for antiviral activity of flavonoids-naturally occurring compounds. Acta Virol.32"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6868923/results/search/funder/results.xml">
   <result pre="antimycobacterial, antigonorrheal and anti-reverse transcriptase activitiesActa Trop201011610010420599632 20LaskowskiRAMacArthurMWMossDSThorntonJMPROCHECK - a" exact="program" post="to check the stereochemical quality of protein structuresJ Appl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6886132/results/search/funder/results.xml">
   <result pre="References 1MurrayCJLopezADChinBFeehanDHillKHEstimation of potential global pandemic influenza mortality on the" exact="basis" post="of vital registry data from the 1918-20 pandemic: A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6889349/results/search/funder/results.xml">
   <result pre="prepared, the raw data were entered into the Excel software" exact="program" post="after which the basic descriptive statistical analyses were performed."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6901432/results/search/funder/results.xml">
   <result pre="viruses with multiple effects on virus replication and propagation. Molecular" exact="basis" post="of ribavirin resistance.Curr. Opin. Virol.810–15. 10.1016/j.coviro.2014.04.01124846716 BoukampP.PetrussevskaR. T.BreitkreutzD.HornungJ.MarkhamA.FusenigN. E."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6907871/results/search/funder/results.xml">
   <result pre="al. (2004) Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression" exact="program" post="by using the viral DNA replication inhibitor cidofovir. Journal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6925523/results/search/funder/results.xml">
   <result pre="innate immune responses. Protein Cell7, 11–1610.1007/s13238-015-0222-9 58SrivastavaS. (2017) The mitochondrial" exact="basis" post="of aging and age-related disorders. Genes8, 39810.3390/genes8120398 59LinT., ChenS.,"/>
   <result pre="al. (2019) Targeting mitochondria in cancer therapy could provide a" exact="basis" post="for the selective anti-cancer activity. PLoS ONE14, e020562310.1371/journal.pone.020562330908483 97AshtonT.,"/>
   <result pre="Cell Biochem.199, 103–10910.1023/A:100691201055010544958 161KlinedinstN.J. and RegenoldW.T. (2014) A mitochondrial bioenergetic" exact="basis" post="of depression. J. Bioenerg. Biomembr.47, 155–17110.1007/s10863-014-9584-625262287 162EtoK., InoueB., OgataM.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6925545/results/search/funder/results.xml">
   <result pre="strategies for management of Epstein–Barr virus (EBV) infection, on the" exact="basis" post="of monitoring of EBV-DNA-emia and pre-emptive or targeted therapy"/>
   <result pre="Diagnosis Viral infections were classified as episodic (diagnosed on the" exact="basis" post="of clinical manifestation and supplemented with appropriate tests) or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6961902/results/search/funder/results.xml">
   <result pre="IFNs than for NAs. We conclude that an individualized therapy" exact="program" post="considering treatment efficacy and side effects is the best"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6963304/results/search/funder/results.xml">
   <result pre="Endocytic Entry of the Porcine Alphaherpesvirus Pseudorabies VirusJ. Virol.201993e01849-1810.1128/JVI.01849-1830355685 26.LiA.LuG.QiJ.WuL.TianK.LuoT.ShiY.YanJ.GaoG.F.Structural" exact="basis" post="of nectin-1 recognition by pseudorabies virus glycoprotein DPLoS Pathog.201713e100631410.1371/journal.ppat.100631428542478"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6968485/results/search/funder/results.xml">
   <result pre="the toxicity to cancer cells was enhanced, which laid a" exact="foundation" post="for the development of new drugs. Keywords Amentoflavone nanomicelle"/>
   <result pre="of the biflavone were analyzed in detail, which laid a" exact="foundation" post="for the pharmacological research and the development of new"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6968529/results/search/funder/results.xml">
   <result pre="at different time intervals. We aimed to provide a meaningful" exact="basis" post="for developing a clinical dose regimen for the treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6970260/results/search/funder/results.xml">
   <result pre="and a clinical training in internal medicine earlier in the" exact="program" post="of education. The physicians filled the questionnaires in during"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6977371/results/search/funder/results.xml">
   <result pre="oseltamivirAntiviral Res200462374515026200 18HaydenGGBruntonLLLazoJSParkerKLAntiviral agents (Non-retroviral)Goodman and Gilman's - The pharmaceutical" exact="basis" post="of therapeutics200511th edNew YorkMcGraw-Hill Professional12589 19ReedLJMuenchHA simple method of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6987146/results/search/funder/results.xml">
   <result pre="attacked by clinically approved drugs are indicated by circles with" exact="orange" post="fill colour (Steps 1, 2, 4, 5, 9). Compound"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC6998849/results/search/funder/results.xml">
   <result pre="to combat PRV are also of great significance. On the" exact="basis" post="of amino acid sequence alignment and molecular biological analyses,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7000641/results/search/funder/results.xml">
   <result pre="enzyme immunoassay method among Korean individuals who underwent health screening" exact="program" post="[120]. More recently, a nationwide seroepidemiology study demonstrated that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7002824/results/search/funder/results.xml">
   <result pre="on Dengue and Chikungunya virus infectionsBMC Complement Altern. Med.201711228049463 69ErbelP.SchieringN.ArcyA.D.RenatusM.KroemerM.LimS.P.YinZ.KellerT.H.VasudevanS.G.HommelU.Structural" exact="basis" post="for the activation of flaviviral NS3 proteases from dengue"/>
   <result pre="vivoVirus Res.2682019111731095989 77ChenW.LiuL.ShenY.HuY.LingF.WangX.ZhuB.PT key laboratory of applied marine biotechnology of" exact="ministry of education," post="ningboCell. Signal.2018 78LiuL.HuY.LuJ.WangG.An imidazole coumarin derivative enhances the antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7004585/results/search/funder/results.xml">
   <result pre="progression of liver fibrosis. This meta-analysis aims to provide a" exact="basis" post="for clinical treatment for CHB, and explore whether KS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7013637/results/search/funder/results.xml">
   <result pre="receives an unrestricted fund from the BGW on an annual" exact="basis" post="to maintain the working group at the UKE. The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7016755/results/search/funder/results.xml">
   <result pre="replicate, thereby inducing host cells’ dysfunction. Virus–host interaction is the" exact="foundation" post="of pathogenesis and closely associated with disease severity and"/>
   <result pre="and regulation of two-pore channel TPC1 from Arabidopsis thalianaNature201653125826210.1038/nature1719426961658 29.HoganP.G.LewisR.S.RaoA.Molecular" exact="basis" post="of calcium signaling in lymphocytes: STIM and ORAIAnnu. Rev."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7016805/results/search/funder/results.xml">
   <result pre="(0.7247 mL/g for DDX3X at 20 °C), were calculated using the" exact="program" post="SEDNTERP (Durham, NH, USA) [24]. Sedimentation velocity data were"/>
   <result pre="fitted to a continuous size (c(s)) distribution model using the" exact="program" post="SEDFIT (Bethesda, MD, USA) [25]. 2.4. Isothermal Titration Calorimetry"/>
   <result pre="activity of yeast Ded1p at lower (nM) RK-33 concentrations. The" exact="basis" post="of this difference in sensitivity is likely due to"/>
   <result pre="to block DDX3X’s ATPase and RNA unwinding activities is the" exact="basis" post="of its broad-spectrum antiviral properties. Supplementary Materials The following"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7019229/results/search/funder/results.xml">
   <result pre="ONE20116e2433410.1371/journal.pone.002433421904628 331.HahnF.FröhlichT.FrankT.BertzbachL.D.KohrtS.KauferB.B.StammingerT.TsogoevaS.B.MarschallM.Artesunate-derived monomeric, dimeric and trimeric experimental drugs—Their unique mechanistic" exact="basis" post="and pronounced antiherpesviral activityAntivir. Res.201815210411010.1016/j.antiviral.2018.02.01329458133 332.HeR.ParkK.CaiH.KapoorA.FormanM.MottB.PosnerG.H.Arav-BogerR.Artemisinin-derived dimer diphenyl phosphate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7022795/results/search/funder/results.xml">
   <result pre="small molecules, such as sulfonamides drugs, could initiate a promising" exact="program" post="of studies on both oncogenic and degenerative diseases, in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7026129/results/search/funder/results.xml">
   <result pre="viruses with multiple effects on virus replication and propagation. Molecular" exact="basis" post="of ribavirin resistance. Curr. Opin. Virol.8, 10–15. 10.1016/j.coviro.2014.04.01124846716 BoonyasuppayakornS.ReichertE."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7032198/results/search/funder/results.xml">
   <result pre="t h e   Ritonavir o r   Efavirenz  " exact="i" post="n   t h e   solvent Initial  "/>
   <result pre="  solvent Initial   concentration   o f particles  " exact="i" post="n   t h e   solvent × 100"/>
   <result pre="(2) σ XRTV 2 = σ CRTV 2   (" exact="m" post="A c e ρ A c e m comp"/>
   <result pre="  ( m A c e ρ A c e" exact="m" post="comp ) 2 + σ mAce 2   ("/>
   <result pre="+ σ mAce 2   ( C RTV ρ Ace" exact="m" post="comp ) 2 + σ mcomp 2   ("/>
   <result pre="σ mcomp 2   ( ( C R T V" exact="m" post="A c e ρ A c e ) ("/>
   <result pre="A c e ρ A c e ) ( 1" exact="m" post="comp 2 ) ) 2 σ W R T"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7040080/results/search/funder/results.xml">
   <result pre="therapeutic approaches.Cell. Mol. Life Sci.713659–3683. 10.1007/s00018-014-1615-161224699705 LukarskaM.FournierG.PflugA.Resa-InfanteP.ReichS.NaffakhN.et al. (2017). Structural" exact="basis" post="of an essential interaction between influenza polymerase and Pol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7045215/results/search/funder/results.xml">
   <result pre="power analysis using the Repeated Measures and Sample Size (RMASS)" exact="program" post="for longitudinal studies and derived the smallest effect size"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7049240/results/search/funder/results.xml">
   <result pre="included substitution therapies with buprenorphine or methadone in a structured" exact="program" post="under the supervision of a multidisciplinary health care team."/>
   <result pre="people with a history of drug use at a community-based" exact="program" post="in Toronto, CanadaInt J Drug Policy20174720220828619394 21NortonBLFlemingJBachhuberMAet al.High HCV"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7049676/results/search/funder/results.xml">
   <result pre="to drug companies adopted by Louisiana,35 or a dedicated linkage‐to‐care" exact="program" post="in Philadelphia, which reported linkage to care in over"/>
   <result pre="B virus infection 30 years after initiation of infant vaccination" exact="program" post="in Taiwan. Clin Gastroenterol Hepatol2016;14:1324‐1330.27155556 48HeywardWL, KyleM, BlumenauJ, DavisM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7050564/results/search/funder/results.xml">
   <result pre="Res2018, 244:321–332.28760348 25. •AllersK, SchneiderT: CCR5Delta32 mutation and HIV infection:" exact="basis" post="for curative HIV therapy. Curr Opin Virol2015, 14:24–29.26143158 This"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7054940/results/search/funder/results.xml">
   <result pre="74.7% (Supplementary data 1). The per cent similarity on nucleotide" exact="basis" post="between nCoV isolates and canine respiratory coronaviruses (CRCoV) and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7064180/results/search/funder/results.xml">
   <result pre="on G/P from Austria. The results may serve as a" exact="basis" post="for further HCV-microelimination strategies. Patients and methods All DAA-naïve"/>
   <result pre="OST program, receiving their OST on a daily or weekly" exact="basis" post="at a pharmacy or a low-threshold facility. It is"/>
   <result pre="pharmacy or at the Ambulatorium Suchthilfe Wien on a once-daily" exact="basis" post="(i.e. from Monday to Saturday and only the doses"/>
   <result pre="in a few cases, on a once-weekly, twice-weekly or thrice-weekly" exact="basis" post="(&quot;directly observed therapy group&quot;). Patients without a history of"/>
   <result pre="live in Vienna and are included in the nationwide OST" exact="program" post="were treated according to the DOT-concept. The outcome of"/>
   <result pre="did not attend their OST distribution facility on a daily" exact="basis" post="but only once, twice or thrice a week and"/>
   <result pre="imprisonment and unstable socioeconomic factors. The inclusion in an OST" exact="program" post="was considered a positive prognostic factor and was used"/>
   <result pre="are planning to introduce a peer-based HCV screening and treatment" exact="program" post="for PWIDs in Vienna. The project shall focus on"/>
   <result pre="fibrosis assessment and HCV treatment initiation within a systematic screening" exact="program" post="in HIV/HCV coinfected patients. Wien Klin Wochenschr. 20182;130(3–4):105–14. 10.1007/s00508-017-1231-x28744597"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7067438/results/search/funder/results.xml">
   <result pre="CA), according to the manufacturer’s directions. The reverse transcription thermocycling" exact="program" post="consisted of 10 minutes at 25°C, 60 minutes at"/>
   <result pre="to BRSV nucleoprotein: forward primer—GCAATGCTGCAGGACTAGGTATAAT and reverse—ACACTGTAATTGATGACCCCATTC. The RT-PCR thermocycling" exact="program" post="consisted of one cycle of 50°C for 2 min"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7070519/results/search/funder/results.xml">
   <result pre="μg/mL and SI ≈ 13333), it may serve as the" exact="basis" post="for future modification in the search for new potent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7070539/results/search/funder/results.xml">
   <result pre="duplex recognition and unwinding by DEAD-box helicase DDX3XNat. Commun.201910308510.1038/s41467-019-11083-231300642 33.SengokuT.NurekiO.NakamuraA.KobayashiS.YokoyamaS.Structural" exact="basis" post="for RNA unwinding by the DEAD-box protein Drosophila VasaCell200612528730010.1016/j.cell.2006.01.05416630817"/>
   <result pre="al.Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a" exact="basis" post="for high virulence of 1918 pandemic influenzaEMBO J.20193810.15252/embj.201899475 107.NiuQ.ChengY.WangH.YanY.SunJ.Chicken"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7073332/results/search/funder/results.xml">
   <result pre="interactome and drug targets in the human PPI network. The" exact="basis" post="for these experiments rests on the notions that (i)"/>
   <result pre="for the HCoV-associated proteins. Network-based drug repurposing for HCoVs The" exact="basis" post="for the proposed network-based drug repurposing methodologies rests on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7076519/results/search/funder/results.xml">
   <result pre="extracts had both antimicrobial and antiviral activity [20]. On the" exact="basis" post="of this, we formulated an NP MIX (0.1 mg/mL)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7076579/results/search/funder/results.xml">
   <result pre="versus resolved) or due to different HBV strains. On the" exact="basis" post="of these data, TNF inhibition in patients with chronic"/>
   <result pre="rituximab: final report of the rheumatoid arthritis global clinical trial" exact="program" post="over 11 years. J Rheumatol2015; 42: 1761–1766.26276965 74VariscoVViganòMBatticciottoA, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7076820/results/search/funder/results.xml">
   <result pre="understanding of this traditional Chinese herb and provide a theoretical" exact="basis" post="for further research. Moreover, Radix isatidis polysaccharide could be"/>
   <result pre="broaden the understanding of Radix isatidis and provide a theoretical" exact="basis" post="for further research. However, more studies are needed to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7077228/results/search/funder/results.xml">
   <result pre="which the other parameters were set as default. The docking" exact="program" post="CDOCKER was used to perform the automated molecular simulation"/>
   <result pre="of HA-OA-10 Binding In order to further understand the molecular" exact="basis" post="of OA-10 interacting with HA, we performed docking experiments"/>
   <result pre="Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaPersonal Communication2019 37.KadamR.U.WilsonI.A.Structural" exact="basis" post="of influenza virus fusion inhibition by the antiviral drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7077276/results/search/funder/results.xml">
   <result pre="and technical assistance on heparin column chromatography from technicians of" exact="general electric" post="(GE) healthcare life sciences. Author Contributions Conceptualization, J.L., J.G."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7077318/results/search/funder/results.xml">
   <result pre="These detailed interactions were analyzed using PyMOL and the LigPlot+" exact="program" post="(Figure 4). The bisulfite group of GC376 was removed,"/>
   <result pre="acute respiratory syndrome coronavirus main proteaseJ. Biol. Chem.2005280227412274810.1074/jbc.M50255620015831489 34.LeeC.C.KuoC.J.KoT.P.HsuM.F.TsuiY.C.ChangS.C.YangS.ChenS.J.ChenH.C.HsuM.C.et al.Structural" exact="basis" post="of inhibition specificities of 3C and 3C-like proteases by"/>
   <result pre="new coronavirus-like particle associated with diarrhea in swineArch. Virol.19785824324710.1007/BF0131760683132 40.YeG.DengF.ShenZ.LuoR.ZhaoL.XiaoS.FuZ.F.PengG.Structural" exact="basis" post="for the dimerization and substrate recognition specificity of Porcine"/>
   <result pre="with GC376. The residues of the protease are shown as" exact="orange" post="sticks and red arcs with spokes. GC376 is shown"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7089181/results/search/funder/results.xml">
   <result pre="treatment for large numbers of exposed and infected individuals. The" exact="basis" post="of all considerations on countermeasures and biothreat preparedness is"/>
   <result pre="the 2014–2016 outbreak [120]. The institute also runs a research" exact="program" post="for antiviral drug development and hosts the biennial Medical"/>
   <result pre="by groups active in the field and is also the" exact="basis" post="of the ‘Antivirals Platform’ collaboration between Cardiff University and"/>
   <result pre="of Crimean-Congo hemorrhagic fever virus in miceAntivir Res2018157182610.1016/j.antiviral.2018.06.01329936152 60.HayAJWolstenholmeAJSkehelJJSmithMHThe molecular" exact="basis" post="of the specific anti-influenza action of amantadineEMBO J198543021302410.1002/j.1460-2075.1985.tb04038.x4065098 61.HolcakovaJTomasecPBugertJJWangECWilkinsonGWHrstkaRKrystofVStrnadMVojtesekBThe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7089605/results/search/funder/results.xml">
   <result pre="Angles (UCLA) are used to test the model [36,37]. The" exact="program" post="used to judge the validity of the model are"/>
   <result pre="complex to reflect the binding potency. Ligands are shown in" exact="orange" post="sticks, while protein residues are in cyan stick representations"/>
   <result pre="and Ribavirin against COVID-19 RdRp are presented. DAAs are in" exact="orange" post="while the protein active site pocket in cyan sticks."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7091548/results/search/funder/results.xml">
   <result pre=", u 4 , u 5 , 0 ≤ u" exact="i" post="≤ u i max , i = 1,2,3,4,5 ."/>
   <result pre=", u 5 , 0 ≤ u i ≤ u" exact="i" post="max , i = 1,2,3,4,5 . To identify the"/>
   <result pre=", 0 ≤ u i ≤ u i max ," exact="i" post="= 1,2,3,4,5 . To identify the required level of"/>
   <result pre="+ A 4 I R p + 1 2 ∑" exact="i" post="= 1 5 q i u i 2 d"/>
   <result pre="p + 1 2 ∑ i = 1 5 q" exact="i" post="u i 2 d t , subject to the"/>
   <result pre="1 2 ∑ i = 1 5 q i u" exact="i" post="2 d t , subject to the differential system:"/>
   <result pre="the set U; that is, (13) ∂ H ∂ u" exact="i" post="= 0. The following set of optimality conditions is"/>
   <result pre="bounds for the controls in U, that is, (15) u" exact="i" post="∗ = 0 , if   u i ¯"/>
   <result pre="(15) u i ∗ = 0 , if   u" exact="i" post="¯ ≤ 0 , u i ¯ , if"/>
   <result pre=", if   u i ¯ ≤ 0 , u" exact="i" post="¯ , if   0 &amp;lt; u i ¯"/>
   <result pre=", u i ¯ , if   0 &amp;lt; u" exact="i" post="¯ &amp;lt; u i max u i max ,"/>
   <result pre=", if   0 &amp;lt; u i ¯ &amp;lt; u" exact="i" post="max u i max , if   u i"/>
   <result pre="0 &amp;lt; u i ¯ &amp;lt; u i max u" exact="i" post="max , if   u i ¯ ≥ u"/>
   <result pre="u i max u i max , if   u" exact="i" post="¯ ≥ u i max in compact notation yields,"/>
   <result pre="i max , if   u i ¯ ≥ u" exact="i" post="max in compact notation yields, (16) u 1 ∗"/>
   <result pre="p 1 ϑ 3 . with pi(T) = 0 for" exact="i" post="= 1,…, 8 and S(0) = S0, Iw(0) ="/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7091927/results/search/funder/results.xml">
   <result pre="influenza A M2 proton channelProc. Natl Acad. Sci. USA20141119396940124979779 35HongMDegradoWFStructural" exact="basis" post="for proton conduction and inhibition by the influenza M2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7093363/results/search/funder/results.xml">
   <result pre="of viral infection. Data on clinical immunity can lay the" exact="foundation" post="for future vaccine development. We need to be aware"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7094090/results/search/funder/results.xml">
   <result pre="only 79% sequence similarity at the genome level.15−18 On the" exact="basis" post="of sequence alignment and homology modeling, SARS-CoV and SARS-CoV-2"/>
   <result pre="efficient therapeutic strategy is to repurpose existing drugs. On the" exact="basis" post="of genomic sequence information coupled with protein structure modeling,"/>
   <result pre="against MERS-CoVNat. Commun.2020, Ahead of Print.10.1038/s41467-019-13940-6 KadamR. U.; WilsonI. A.Structural" exact="basis" post="of influenza virus fusion inhibition by the antiviral drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7095077/results/search/funder/results.xml">
   <result pre="COVID-19. To improve detection efficiency, front-line clinics, apart from local" exact="centers for disease control and prevention," post="should be armed with validated point-of-care diagnostic kits. Education"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7096384/results/search/funder/results.xml">
   <result pre="virus addition resulted in very little antiviral effect (Figure 5," exact="orange" post="bar), indicating that CATH-B1 was efficiently removed from solution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7097833/results/search/funder/results.xml">
   <result pre="infused over an hour. Additional administration(s) are evaluated on the" exact="basis" post="of patient’s response to TCZ 8-12 hours apart, in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7100484/results/search/funder/results.xml">
   <result pre="The training data was generated through a large collaborative drug-repurposing" exact="program" post="that identified multiple classes of Ebola inhibitors with in"/>
   <result pre="in prophylaxis of acute respiratory viral infections]. Zhurnal mikrobiologii, epidemiologii," exact="i" post="immunobiologii. 2001(3):42–46. 11.Anon. Amixin. Available from: https://rupharma.com/amixin/. 12.KruegerREMayerGDTilorone hydrochloride:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102518/results/search/funder/results.xml">
   <result pre="clinical development. Abbreviations RBC, red blood cells PK, pharmacokinetics CDC," exact="centers for disease control and prevention" post="IAV, influenza A virus IBV, influenza B virus RdRP,"/>
   <result pre="proton-selective ion channelProc Natl Acad Sci U S A1052008109671097218669647 19StoufferA.L.AcharyaR.SalomD.Structural" exact="basis" post="for the function and inhibition of an influenza virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102521/results/search/funder/results.xml">
   <result pre="Acad Sci U S A1031520065717572216581910 30AnandK.ZiebuhrJ.WadhwaniP.MestersJ.R.HilgenfeldR.Coronavirus main proteinase (3CLpro) structure:" exact="basis" post="for design of anti-SARS drugsScience300562620031763176712746549 31XuY.LouZ.LiuY.PangH.TienP.GaoG.F.Crystal structure of severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102522/results/search/funder/results.xml">
   <result pre="Approaches for the development of anti-viral drugs Typically, the drug-discovery" exact="program" post="to develop new potent anti-viral agents and to obtain"/>
   <result pre="mouse brain and markedly increases the alkylating DNA damageCarcinogenesis35201469270224193513 94GalkinA.Structural" exact="basis" post="for inactivation of giardia lamblia carbamate kinase by disulfiramJ."/>
   <result pre="blocks E protein ion channels and inhibits coronavirus replicationVirology353200629430616815524 163LinS.Y.Structural" exact="basis" post="for the identification of the N-terminal domain of coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102570/results/search/funder/results.xml">
   <result pre="traditional medicine, in influenza virus-infected miceChem Pharm Bull (Tokyo)461998144414479775439 KurosakiK.MiwaN.YoshidaY.KurokawaM.KurimotoM.EndoS.ShirakiK.Therapeutic" exact="basis" post="of vidarabine on adenovirus-induced haemorrhagic cystitisAntiviral Chemistry &amp;amp; Chemotherapy15200428128515535050"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102646/results/search/funder/results.xml">
   <result pre="are represented by yellow spheres connected by black dashed lines," exact="orange" post="dashed lines, and cyan lines, respectively. RdRp residues are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102647/results/search/funder/results.xml">
   <result pre="biology, electrophysiology, and virology have produced crucial information about the" exact="basis" post="of M2-based drug resistance. This in turn has shed"/>
   <result pre="complex structures originating from computational studies have also formed the" exact="basis" post="of structure-based drug design. As of this writing, there"/>
   <result pre="posttranslational modifications of the influenza virus M2 proteinJ. Virol.691995121912257529332 HongM.DeGradoW.F.Structural" exact="basis" post="for proton conduction and inhibition by the influenza M2"/>
   <result pre="of influenza A virus cores after penetrationJ. Virol.882014130291304610.1128/JVI.01430-1425165113 StoufferA.L.AcharyaR.SalomD.LevineA.S.Di CostanzoL.SotoC.S.TereshkoV.NandaV.StayrookS.DeGradoW.F.Structural" exact="basis" post="for the function and inhibition of an influenza virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7102657/results/search/funder/results.xml">
   <result pre="of dimeric full-length human ACE2 in complex with B0AT1bioRxiv202010.1101/2020.02.17.951848 8YanR.Structural" exact="basis" post="for the recognition of SARS-CoV-2 by full-length human ACE2Science36720201444144810.1126/science.abb276232132184"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7103671/results/search/funder/results.xml">
   <result pre="Rev Vaccines. 2016;15(9):1123–34. doi:10.1586/14760584.2016.1167603.26985862 50.EnjuanesL, ZuñigaS, Castaño-rodriguezC, Gutierrez-AlvarezJ, CantonJ, SolaIMolecular" exact="basis" post="of coronavirus virulence and vaccine development. Adv Virus Res."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7104317/results/search/funder/results.xml">
   <result pre="transmembrane domain and the cytoplasmic signal domain [12]. The structural" exact="basis" post="for TLR3 interaction with dsRNA is the extracellular variable"/>
   <result pre="to induce synthesis of IFN and other cytokines is a" exact="basis" post="for diversity of their immunomodulatory properties. It has been"/>
   <result pre="viruses [51], some fungi contain dsRNA elements [52]. On the" exact="basis" post="of this type of dsRNA, Ridostin and Larifan preparations"/>
   <result pre="lower than of PolyG:PolyC and PolyI:PolyC [61]. Currently, on the" exact="basis" post="of PolyA:PolyU, the drug Poludan (manufactured by Lance-Farm LLC,"/>
   <result pre="B16BL6 melanoma. dsRNA delivery systems are also developed on the" exact="basis" post="of inorganic molecules. For example, iron oxide nanoparticles were"/>
   <result pre="(MUC1). However, fully synthetic glycopeptide tumor vaccines created on the" exact="basis" post="of this glycopeptide are characterized by low immunogenicity. Glaffig"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7105343/results/search/funder/results.xml">
   <result pre="coronavirus protease inhibitor has yet successfully completed a preclinical development" exact="program" post="[8] Respiratory Viral Infections in Patients With Cancer or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7114304/results/search/funder/results.xml">
   <result pre="for large spectrum inhibitors. In 2009 and 2010, a structural" exact="basis" post="for the inhibition mechanisms was provided by the crystal"/>
   <result pre="the respiratory syncytial virus mRNAJ. General Virol.74Pt 31993485490 BenarrochD.EgloffM.P.MulardL.GuerreiroC.RometteJ.L.CanardB.A structural" exact="basis" post="for the inhibition of the NS5 dengue virus mRNA"/>
   <result pre="of catalysis and regulationCurr. Opin. Chem. Biol.219986336419818190 DespinsS.IssurM.BougieI.BisaillonM.Deciphering the molecular" exact="basis" post="for nucleotide selection by the West Nile virus RNA"/>
   <result pre="formation of covalent complex p126–m7GMPFEBS Lett.4551999454810428469 MilaniM.MastrangeloE.BollatiM.SeliskoB.DecrolyE.BouvetM.CanardB.BolognesiM.Flaviviral methyltransferase/RNA interaction: structural" exact="basis" post="for enzyme inhibitionAntiviral Res.832009283419501254 MorinB.CoutardB.LelkeM.FerronF.KerberR.JamalS.FrangeulA.BarontiC.CharrelR.de LamballerieX.VonrheinC.LescarJ.BricogneG.GüntherS.CanardB.The N-terminal domain of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7114316/results/search/funder/results.xml">
   <result pre="binding site residues, and calculating the partial charge using the" exact="program" post="Chimera (UCSF, San Francisco, USA). The prepared structures were"/>
   <result pre="analysis Initial virtual screening studies were carried out using the" exact="program" post="AutoDock Vina (Trott and Olson, 2010), which was built"/>
   <result pre="selected compounds were re-scored using different docking algorithms on the" exact="program" post="GOLD version 5.5 (license kindly provided by Assoc. Prof."/>
   <result pre="fitness function for ranking of the binding affinity. The second" exact="program" post="for re-scoring, ICM-pro suite version 3.8.6, was used to"/>
   <result pre="performances. The interactions of protein-ligand complexes were characterized using the" exact="program" post="LigPlot version 1.4.5. (Laskowski and Swindells, 2011) and the"/>
   <result pre="calculate the kinetic parameters using the Michaelis-Menten equation on the" exact="program" post="KaleidaGraph. For the protease inhibition assay, the initial rates"/>
   <result pre="kinetic data were fitted using nonlinear regression on the computer" exact="program" post="KinetAsyst II (IntelliKinetics, State College, PA), to obtain the"/>
   <result pre="3CLpro Molecular docking analyses were initially carried out using the" exact="program" post="Autodock Vina, and then re-docked using the GOLD and"/>
   <result pre="of FIPV 3CLpro was determined as −8.3 kcal/mol using the" exact="program" post="Autodock Vina. On the other hand, NSC87511 had SI"/>
   <result pre="displaying SARS-CoV 3CLpro inhibitionBioorg. Med. Chem.1820107940794720934345 SanderT.FreyssJ.von KorffM.RufenerC.DataWarrior: an open-source" exact="program" post="for chemistry aware data visualization and analysisJ. Chem. Inf."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7117595/results/search/funder/results.xml">
   <result pre="(2018).28685814 14.FerronF , SubissiL , DeMorais ATSet al.Structural and molecular" exact="basis" post="of mismatch correction and ribavirin excision from coronavirus RNA."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7118362/results/search/funder/results.xml">
   <result pre="the clinical and functional conditions and not only on the" exact="basis" post="of age. For the healthcare system in all the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7118423/results/search/funder/results.xml">
   <result pre="severe cases. A randomised controlled trial shows that on the" exact="basis" post="of Western medicine treatment, XueBiJing injection could significantly reduce"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7118659/results/search/funder/results.xml">
   <result pre="HLA class Ih Sialic acid (O-acetylated sialic acid) ? MERS-CoV" exact="i" post="Dipeptidyl peptidase 4 (DPP4)/CD26 Yes SARS-CoV-2 ACE2i Sialic acid?"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120034/results/search/funder/results.xml">
   <result pre="mitochondria and mitophagy in sustaining human health and the molecular" exact="basis" post="of their defects in the etiology of aging diseases."/>
   <result pre="This specificity is usually determined by comparing sugars on the" exact="basis" post="of the minimum concentration needed to inhibit hemagglutination. If"/>
   <result pre="that both the likely molecular target for CV-N and the" exact="basis" post="of CV-N resistance resided in the viral particle [63]."/>
   <result pre="virus growth need to be further explored to know the" exact="basis" post="of their biological activity. Plant Lectins as Antibacterial and"/>
   <result pre="molecular level need to be further explored to know the" exact="basis" post="of their biological activity. Although there is still much"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120377/results/search/funder/results.xml">
   <result pre="of its own genes while simultaneously shutting down the transcriptional" exact="program" post="of its host cell [4]. TNF-α levels are increased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120516/results/search/funder/results.xml">
   <result pre="al. 2010). Novel genotyping strategies are emerging on a regular" exact="basis" post="using a variety of techniques designed to increase the"/>
   <result pre="of drug resistance phenotypes for HIV-1 protease on a patient-by-patient" exact="basis" post="(Shenderovich et al. 2003). The interaction and movements of"/>
   <result pre="and specificity for predicting drug resistance phenotypes on a patient-by-patient" exact="basis" post="for various Food and Drug Administration (FDA; http://www.fda.gov)-approved drugs,"/>
   <result pre="du Praticien2000501066107010905090 DoyleSESchreckhiseHKhuu-DuongKet al.Interleukin-29 uses a type 1 interferon- like" exact="program" post="to promote antiviral responses in human hepatocytesHepatology20064489690617006906 Dragsted U,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120554/results/search/funder/results.xml">
   <result pre="a literature reviewJ Saudi Chem Soc201721222923710.1016/j.jscs.2016.08.001 AlimbarovaLet al.Composition on the" exact="basis" post="of phosphonoacetic acid. Synthesis and antiviral activityRuss J Gen"/>
   <result pre="poliovirusJ Gen Virol198667112415242210.1099/0022-1317-67-11-24152431100 PerazellaMAShiraliAKidney disease caused by therapeutic agentsNational kidney" exact="foundation" post="primer on kidney diseases20146PhiladelphiaElsevier326336 Plummer CE, Colitz CM, Kuonen"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120890/results/search/funder/results.xml">
   <result pre="Armstrong EJ et al (2009) Principles of pharmacology: the patho­physiologic" exact="basis" post="of drug therapy. Wolters Kluwer Health/Lippincott Williams &amp;amp; Wilkins,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7120914/results/search/funder/results.xml">
   <result pre="taste, and pigment of plants.1 Terpenes are classified on the" exact="basis" post="of organization and number of isoprene units it contains"/>
   <result pre="bacteria, and plants and mainly responsible for red, yellow, or" exact="orange" post="fat-soluble plant and animal pigments (see footnote 6). One"/>
   <result pre="Limonene is a bioactive food component found in citrus peels," exact="orange" post="peels, and several other citrus fruits (Jirtle et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7121112/results/search/funder/results.xml">
   <result pre="that these techniques are performed frequently and on a regular" exact="basis" post="in molecular diagnostic laboratories. Automation of the workflow from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7121504/results/search/funder/results.xml">
   <result pre="individuals may or may not reduce risky behaviors on the" exact="basis" post="of the current risk perception of the epidemic. The"/>
   <result pre="adopt two mutually exclusive behaviors, &quot;normal&quot;bn and &quot;altered&quot;ba, on the" exact="basis" post="of the perceived risk of infection. We assume that"/>
   <result pre="etiquette). In the model, spontaneous behavioral changes occur on the" exact="basis" post="of cost/benefit considerations. This assumption perfectly fits the language"/>
   <result pre="altering the perception of the risk of infection on the" exact="basis" post="of the number of cases occurred over a certain"/>
   <result pre="The timing of the behavioral response is characterized by parameters" exact="m" post="and ρ. The former describes how the perceived prevalence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7121845/results/search/funder/results.xml">
   <result pre="The grenade can be thrown by hand up to 30" exact="m" post="to the hideouts/agitated mob. The grenades when applied emit"/>
   <result pre="petals: 3–4 mm long, united utricles subglobose, succulent, red and" exact="orange" post="coloured. Seeds are solitary, unequally bilobed, light, black and"/>
   <result pre="flower which grows in clusters and is found at &amp;gt;4000" exact="m" post="in the high-altitude Himalayan ranges from Leh, Ladakh, India."/>
   <result pre="a major challenge that needs to be tackled on priority" exact="basis" post="(Photo Credit: National Institute of Allergy and Infectious Diseases,"/>
   <result pre="interactive platform. The priority index algorithms were used as a" exact="basis" post="for evaluation of relevance factor of various physiological targets"/>
   <result pre="Tanwar et al. 2017a,b). Similarly, the potential herbals identified the" exact="basis" post="of classical bioprospection were subjected to binary, weightage and"/>
   <result pre="storage facility and modern laboratory at Chang La top (5360" exact="m" post="AMSL) in Ladakh exploiting the naturally existing sub-zero temperature"/>
   <result pre="plant productsMicrob Pathog201692768510.1016/j.micpath.2016.01.00126792674 VasinMVClassification of radiation protective agents as a" exact="basis" post="of modern radiation pharmacologyRadiats Biol Radioecol19993921222210366943 VijayaraghavanRGautamAKumarOPantSCSharmaMSinghSKumarHTSinghAKNivsarkarMKaushikMPSawhneyRCChaurasiaOPPrasadGBProtective effect of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7122247/results/search/funder/results.xml">
   <result pre="the furin inhibitory nanobody Nb14, shown in cartoon style in" exact="orange" post="(PDB, 5JMO) (Dahms et al. 2016b). Although the nanobody"/>
   <result pre="ovomucoid third domain inhibits human furinJ Biol Chem199326814583145858325837 LuGHuYWangQQiJGaoFLiYZhangYZhangWYuanYBaoJet al.Molecular" exact="basis" post="of binding between novel human coronavirus MERS-CoV and its"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7122610/results/search/funder/results.xml">
   <result pre="increasing public health crises and have been persistently seeking a" exact="new balance" post="between patent protection and the public health interest of"/>
   <result pre="advancement of the WTO regulations are needed to establish a" exact="new balance" post="between the protection of intellectual property of medicines and"/>
   <result pre="promise to provide free ARV drugs for the national treatment" exact="program" post="once they gain access to the international market [38]."/>
   <result pre="diseases. Due to the lack of such collaboration, the initial" exact="sparks" post="of HIV infections in central Africa become a global"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7122614/results/search/funder/results.xml">
   <result pre="trials conducted in the late 1990s that served as the" exact="basis" post="for approval of zanamivir and oseltamivir in 1999 and,"/>
   <result pre="Immunization Practices (ACIP)MMWR Recomm Rep201160112421248682 3.Hay AJ et al. Molecular" exact="basis" post="of resistance of influenza A viruses to amantadine. J"/>
   <result pre="related agentsAntimicrobial therapy and vaccines1999Baltimore, MDWilliams and Wilkins134465 18.BelsheRBet al.Genetic" exact="basis" post="of resistance to rimantadine emerging during treatment of influenza"/>
   <result pre="of influenza virus resistance to neuraminidase inhibitorsVirus Res20041031–219920310.1016/j.virusres.2004.02.03415163510 113.CollinsPJet al.Structural" exact="basis" post="for oseltamivir resistance of influenza virusesVaccine2009274563172310.1016/j.vaccine.2009.07.01719840667 114.SamsonMet al.Characterization of"/>
   <result pre="experience with intravenous zanamivir under an emergency investigational new drug" exact="program" post="in the United StatesJ Infect Dis20132071196810.1093/infdis/jis63723089591 184.Chan-TackKMet al.Clinical experience"/>
   <result pre="184.Chan-TackKMet al.Clinical experience with intravenous zanamivir under an Emergency IND" exact="program" post="in the United States (2011–2014)Antivir Ther2015205561410.3851/IMP294425667992 185.FraaijPLet al.Evaluation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7122828/results/search/funder/results.xml">
   <result pre="did not respond to chloroquine. Again, a new drug prospection" exact="program" post="was conducted, in which Dapsone, Pyrimethamine, Sulfadoxine, Sulfalene, Mefloquine,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7123767/results/search/funder/results.xml">
   <result pre="can act as an antiviral drug and may form the" exact="basis" post="for the development of new drugs against coronavirus infection."/>
   <result pre="Current by Kaempferol Triglycosides Kaempferol glycosides may also form the" exact="basis" post="for new drugs against influenza A. A triglycoside has"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7125728/results/search/funder/results.xml">
   <result pre="with (S)-18F-FPMPA. Areas of highest tracer retention are shown in" exact="orange" post="and red. From Di Mascio et al. (2009b), with"/>
   <result pre="The broad substrate specificity of the HSV TK is the" exact="basis" post="of antiviral therapy with acyclovir and other nucleoside analogues."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7126206/results/search/funder/results.xml">
   <result pre="the main treatment is to strengthen healthy energy. On the" exact="basis" post="of the ancient prescription Yihuang Decoction, a classic prescription"/>
   <result pre="into host cells using temperature control technology. It laid a" exact="foundation" post="for exploring the mechanism of JZ-1's inhibitory effect on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7127693/results/search/funder/results.xml">
   <result pre="interaction map for clinical kinase inhibitorsNat. Biotechnol.233200532933615711537 FalconV.Acosta-RiveroN.GonzalezS.Duenas-CarreraS.Martinez-DonatoG.MenendezI.GarateixR.SilvaJ.A.AcostaE.KouriJ.Ultrastructural and biochemical" exact="basis" post="for hepatitis C virus morphogenesisVirus Genes532201715116428233195 FayN.PantéN.Nuclear entry of"/>
   <result pre="SongY.H.KimD.W.Curtis-LongM.J.YukH.J.WangY.ZhuangN.LeeK.H.JeonK.S.ParkK.H.Papain-like protease (PLpro) inhibitory effects of cinnamic amides from &amp;lt;" exact="i" post="&amp;gt; tribulus terrestris fruitsBiol. Pharm. Bull.37620141021102824882413 SportsmanJ.R.GaudetE.A.BogeA.Immobilized metal ion"/>
   <result pre="VPS4 inhibit rhabdovirus budding without affecting alphavirus buddingJ. Virol.81242007136311363917913808 TeruyaK.HattoriY.ShimamotoY.KobayashiK.SanjohA.NakagawaA.YamashitaE.AkajiK.Structural" exact="basis" post="for the development of SARS 3CL protease inhibitors from"/>
   <result pre="protease from a global infectious human coronavirus, HCoV-HKU1J. Virol.821720088647865518562531 ZhaoY.SohT.S.LimS.P.ChungK.Y.SwaminathanK.VasudevanS.G.ShiP.-Y.LescarJ.LuoD.Molecular" exact="basis" post="for specific viral RNA recognition and 2′-O-ribose methylation by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7128351/results/search/funder/results.xml">
   <result pre="of the published cases referred patients using TCM on the" exact="basis" post="of chemical drug therapy. For example, Cheng Dezhong et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7128376/results/search/funder/results.xml">
   <result pre="an in-depth knowledge about the receptors and its targets and" exact="basis" post="of viral replication would be a stepping stone to"/>
   <result pre="their body parts. Hence, it is important to stay &amp;gt;1" exact="m" post="(3 ft) away from a person who is sick"/>
   <result pre="viruses with multiple effects on virus replication and propagation. Molecular" exact="basis" post="of ribavirin resistanceCurr. Opin. Virol.82014101510.1016/j.coviro.2014.04.01124846716 BeckB.R.ShinB.ChoiY.ParkS.KangK.Predicting commercially availableantiviral drugs"/>
   <result pre="J. Med.36720121814182010.1056/NEJMoa121172123075143 ZhangL.LinD.SunX.CurthU.DrostenC.SauerheringL.BeckerS.RoxK.HilgenfeldR.Crystal structure of SARS-CoV-2 main protease provides a" exact="basis" post="for design of improved α-ketoamide inhibitorsScience2020eabb340510.1126/science.abb3405 ZhaoY.ZhaoZ.WangY.ZhouY.MaY.ZuoW.Single-cell RNA expression"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7128473/results/search/funder/results.xml">
   <result pre="staff should be minimised wherever possible. Face-to-face contact is the" exact="basis" post="for the physician-patient relationships and allows physicians to quickly"/>
   <result pre="many countries and areas. •Reducing the in-hospital liver transplant evaluation" exact="program" post="to the strictly necessary is recommended to shorten the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7128678/results/search/funder/results.xml">
   <result pre="2 is a functional receptor for the SARS coronavirusNature426200345045414647384 9YanR.ZhangY.LiY.XiaL.GuoY.ZhouQ.Structural" exact="basis" post="for the recognition of the SARS-CoV-2 by full-length human"/>
   <result pre="SARS-CoV entry into Vero E6 cellsBiochem Biophys Res Commun369200834434918279660 23TortoriciM.A.WallsA.C.LangY.WangC.LiZ.KoerhuisD.Structural" exact="basis" post="for human coronavirus attachment to sialic acid receptorsNat Struct"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7129715/results/search/funder/results.xml">
   <result pre="hospitalized patients. Various drugs have been empirically used on the" exact="basis" post="of their in vitro antiviral or anti-inflammatory properties, except"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7132364/results/search/funder/results.xml">
   <result pre="chloroquine and HIV-1 infectionHIV Med.16201558559026238012 Chinese Clinical Trial Register (ChiCTR)The" exact="world health organization" post="international clinical trials registered organization registered platformaccessed 3.1.20http://www.chictr.org.cn/enIndex.aspx ColsonP.RolainJ.-M.RaoultD.Chloroquine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7134866/results/search/funder/results.xml">
   <result pre="by the French Government under the ‘Investments for the Future’" exact="program" post="managed by the National Agency for Research (ANR) [Méditerranée-Infection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7135139/results/search/funder/results.xml">
   <result pre="by the French Government under the ‘Investments for the Future’" exact="program" post="managed by the National Agency for Research (ANR) [Méditerranée"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7136267/results/search/funder/results.xml">
   <result pre="three regions with two strong and weak signal intensities for" exact="orange" post="carotenoids, with a strong band at 1380 cm−1, which corresponds"/>
   <result pre="apoptosis was also evaluated by dual nuclear staining with acridine" exact="orange" post="and ethidium bromide using a fluorescence microscope. Green fluorescence"/>
   <result pre="shown in Fig. 5C, pigment-treated cancer cells mainly exhibited yellow," exact="orange" post="and red fluorescence, while 5-FU-treated cancer cells still demonstrated"/>
   <result pre="cancer cells and untreated cancer cells after staining with acridine" exact="orange" post="and ethidium bromide and investigation using fluorescence microscopy (green,"/>
   <result pre="growth and carotenoid production by this strain15. After extraction, the" exact="orange" post="pigment in this study was characterized using FTIR, Raman"/>
   <result pre="with alternating single and double bond and exhibit yellow to" exact="orange" post="colour. Various pigments, including phytoene, β-carotene, lycopene and salinixanthin"/>
   <result pre="illustrated the RNA polymerase (NS5B) inhibition-dependent anti-HCV activity of Monascus" exact="orange" post="pigment, which suppresses NS5B activity by 28% at a"/>
   <result pre="of this gene, which were then sequenced, and the BLAST" exact="program" post="was used to assess similarity. Microscopic examination For electron"/>
   <result pre="assayed by two fluorescent nuclear stains (ethidium bromide and acridine" exact="orange" post="dyes). The untreated and treated cancer cells were stained"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7138017/results/search/funder/results.xml">
   <result pre="can lead to acute resolved or fatal pneumonia. On the" exact="basis" post="of knowledge of other coronaviruses, the main route of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7139247/results/search/funder/results.xml">
   <result pre="e00221-18 86HammerQRuckertTRomagnaniCNatural killer cell specificity for viral infectionsNat Immunol19201880080810.1038/s41590-018-0163-630026479 87DaiHSCaligiuriMA.Molecular" exact="basis" post="for the recognition of herpes simplex virus type 1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7139252/results/search/funder/results.xml">
   <result pre="Council for Nutritional and Environmental Medicine, Toften 24, 8610 Mo" exact="i" post="Rana, Norway. bjorklund@conem.org pmc-release: 2020-4-4ppub: 2020-6epub: 2020-4-4215108409108409received: 2020-3-30rev-recd: 2020-4-4accepted:"/>
   <result pre="(Accessed: 7 April 2020) 103ShankarA.H.PrasadA.S.Zinc and immune function: the biological" exact="basis" post="of altered resistance to infectionAm. J. Clin. Nutr.681998447S463S9701160 104ReadS.A.ObeidS.AhlenstielC.AhlenstielG.The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drugDebug/PMC7140116/results/search/funder/results.xml">
   <result pre="IrsiCaixa and the Ethics Review Board of Hospital Germans Trias" exact="i" post="Pujol. Buffy coats were purchased from the Catalan Banc"/>
   <result pre="Buffy coats were purchased from the Catalan Banc de Sang" exact="i" post="Teixits (http://www.bancsang.net/en/index.html). The buffy coats received were totally anonymous"/>
   <result pre="were performed in the Histopatology core facility at Germans Trias" exact="i" post="Pujol Research Institute. A polyclonal rabbit anti-SAMHD1 antibody (cat."/>
   <result pre="therapeutic target in acute myeloid leukemiaNat. Med.20172325025510.1038/nm.425527991919 30.KnechtK.M.BuzovetskyO.SchneiderC.ThomasD.SrikanthV.KaderaliL.TofoleanuF.ReissK.FerreirósN.GeisslingerG.et al.The structural" exact="basis" post="for cancer drug interactions with the catalytic and allosteric"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
